NCT02525653View on ClinicalTrials.gov

Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Lung CancerUntreated Stage IV or Recurrent Squamous Cell Lung Cancers
Interventions
DRUG

albumin-bound paclitaxel

DRUG

gemcitabine

Trial Locations (6)

10065

Memorial Sloan Kettering Cancer Center, New York

10591

Memorial Sloan Kettering Westchester, Sleepy Hollow

11725

Memorial Sloan Kettering Commack, Commack

33143

Miami Cancer Institute Baptist Health South Florida, Miami

07920

Memorial Sloan Kettering at Basking Ridge, Basking Ridge

Unknown

Memorial Sloan Kettering Rockville Centre, Rockville Centre

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

collaborator

Miami Cancer Institute

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER